Morgan Stanley’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-7,073
| Closed | -$41K | – | 6964 |
|
2019
Q1 | $41K | Sell |
7,073
-136,979
| -95% | -$794K | ﹤0.01% | 5759 |
|
2018
Q4 | $188K | Buy |
144,052
+38,803
| +37% | +$50.6K | ﹤0.01% | 5310 |
|
2018
Q3 | $363K | Buy |
105,249
+32,672
| +45% | +$113K | ﹤0.01% | 5165 |
|
2018
Q2 | $330K | Buy |
72,577
+307
| +0.4% | +$1.4K | ﹤0.01% | 5331 |
|
2018
Q1 | $239K | Buy |
72,270
+6,600
| +10% | +$21.8K | ﹤0.01% | 5397 |
|
2017
Q4 | $256K | Sell |
65,670
-68,622
| -51% | -$268K | ﹤0.01% | 5324 |
|
2017
Q3 | $1.39M | Buy |
134,292
+74,640
| +125% | +$773K | ﹤0.01% | 4197 |
|
2017
Q2 | $582K | Buy |
59,652
+41,354
| +226% | +$403K | ﹤0.01% | 4703 |
|
2017
Q1 | $124K | Sell |
18,298
-26,443
| -59% | -$179K | ﹤0.01% | 5522 |
|
2016
Q4 | $247K | Buy |
44,741
+42,063
| +1,571% | +$232K | ﹤0.01% | 5273 |
|
2016
Q3 | $20K | Sell |
2,678
-2,150
| -45% | -$16.1K | ﹤0.01% | 5918 |
|
2016
Q2 | $40K | Buy |
4,828
+4,247
| +731% | +$35.2K | ﹤0.01% | 5607 |
|
2016
Q1 | $8K | Buy |
581
+343
| +144% | +$4.72K | ﹤0.01% | 6201 |
|
2015
Q4 | $5K | Sell |
238
-1,697
| -88% | -$35.7K | ﹤0.01% | 6400 |
|
2015
Q3 | $24K | Sell |
1,935
-2,077
| -52% | -$25.8K | ﹤0.01% | 6000 |
|
2015
Q2 | $83K | Sell |
4,012
-51,226
| -93% | -$1.06M | ﹤0.01% | 5680 |
|
2015
Q1 | $1.17M | Buy |
55,238
+47,127
| +581% | +$995K | ﹤0.01% | 4010 |
|
2014
Q4 | $250K | Buy |
8,111
+7,936
| +4,535% | +$245K | ﹤0.01% | 5109 |
|
2014
Q3 | $3K | Buy |
+175
| New | +$3K | ﹤0.01% | 6426 |
|